Abstract
The expression of intercellular adhesion molecule (ICAM-1) and vascular cell adhesion molecule (VCAM-1) were studied in the conjunctiva of diabetic patients with and without retinopathy. All patients underwent a complete ophthalmic examination including ocular fundus and retinal fluorescein angiography. The indirect immunoperoxidase method was performed on 15 normal conjunctivas taken during cataract surgery (group 1), on 40 eyes of 40 patients with type 2 diabetes without diabetic retinopathy (DR) (group 2) and 13 eyes of 13 patients with DR (group 3). ICAM-1 and VCAM-1 are located in epithelial cells, vascular endothelial cells and in stromal cells. Our results show a statistically significant increase in the immunohistochemical expression of these proteins in the conjunctiva of diabetic patients with and without DR in comparison with normal conjunctiva (P = 0.001). Noteworthy, ICAM-1 and VCAM-1 are upregulated in the conjunctiva of diabetic patients with and without retinopathy, reflecting the inflammatory nature of this condition and suggesting a possible role for these mediators in the pathogenesis of diabetic microangiopathy.
Similar content being viewed by others
References
Abu-El-Asrar AM, Geboes K, Al-Kharashi S, Tabbara KF, Missotten L, Desmet V (1997) Adhesion molecules in vernal keratoconjunctivitis. Br J Ophthalmol 81:1099–1106
Abu-El-Asrar AM, Dralands L, Missoten L, Al-Jadaan IA, Geboes K (2004) Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis 45:2760–2766
Adamis AP (2002) Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol 86:363–365
Altannavch TS, Roubalova K, Kucera P, Andel M (2004) Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without cytokine activation. Physiol Res 53:77–82
Archer DB (1999) Diabetic retinopathy: some cellular, molecular and therapeutic considerations. Eye 13:497–523
Barile GR, Chang SS, Park LS, Reppucci VS, Schiff WM, Schmidt AM (1999) Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Curr Eye Res 19:219–227
Chakrabarti S, Cukiernik M, Hileeto D, Evans T, Chen S (2000) Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy. Diabetes Metab Res Rev 16:393–407
Chen W, Jump DB, Grant MB, Esselman WJ, Busik JV (2003) Dyslipidemia, but not hyperglycemia, induces inflammatory adhesion molecules in human retinal vascular endothelial cells. Invest Ophthalmol Vis Sci 44:5016–5022
Cheung AKH, Fung MKL, Lo ACY, Lam TTL, So KF, Chung SSM, Chung SK (2005) Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes 54:3119–3125
Ciulla TA, Harris A, Latkany P, Piper HC, Arend O, Garzozi H, Martin B (2002) Ocular perfusion abnormalities in diabetes. Acta Ophthalmol Scand 80:468–477
Fong DS, Atello L, Gardner TW, King JL, Blankenship G, Cavallerano JD, Ferris FL, Klein R (2003) Diabetic retinopathy. Diabetes Care 26:226–229
Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koisumi K, Dohmen S, Adamis AP (2002a) Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-α suppression. FASEB J 16:438–440
Joussen AM, Poulaki V, Tsujikawa A, Qin W, Quam T, Xu Q, Moromizato Y, Bursell SE, Wiegand SJ, Rudge J, Loffe E, Yancopoulos GD, Adamis AP (2002b) Suppression of diabetic retinopathy with angiopoitin-1. Am J Pathol 160:1683–1693
Joussen AM, Poulaki V, Le ML (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 10:1–17
Kowluru RA, Odenbach S (2004) Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. Br J Ophthalmol 88:1343–1347
Kria L, Khalfaoui T, Mkannez G, Beltaief O, Anane R, Errais K, Tounsi L, Zhioua R, Jilani SB, Ouertani AM (2005) Immunohistochemical study of vascular endothelial growth factor (VEGF), tumor suppressor protein (p53) and intercellular adhesion molecule (ICAM-1) in the conjunctiva of diabetic patients. J Mol Histol 36:381–390
Limb GA, Hickman-Casey J, Hollifield RD, Chignell AH (1999) Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 40:2453–2457
Lloyd PA (1997) Clinical implications of vascular growth factors in proliferative retinopathies. Curr Opin Ophthalmol 8:19–31
Manaviat MR, Afkhami M, Shoja MR (2004) Retinopathy and microalbumineria in type II diabetic patients. BMC Ophthalmol 4:1471–1475
McLeod DS, Lefer DJ, Merges C, Lutty GA (1995) Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 147:642–653
Meleth AD, Agron E, Chan CC, Reed GF, Arora K, Byrnes G, Csaky KG, Ferris FL, Chew EY (2005) Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 46:4295–4301
Platts KE, Benson MT, Rennie IG, Sharrard RM, Rees RC (1995) Cytokine modulation of adhesion molecule expression on human retinal pigment epithelial cells. Invest Ophtalmol Vis Sci 36:2262–2269
Sampson MJ, Davies IR, Brown JC, Ivory K, Hughes DA (2002) Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment type 2 diabetes and control patients. Arterioscler Thromb Vasc Biol 22:1187–1193
Sangwan VS, Merchant A, De la Maza MS, Foster S (1998) Leucocyte adhesion molecule expression in scleritis. Arch Ophthalmol 116:1476–1480
Santos KG, Schneider JR, Souta KEP, Roisenberg I (2005) Prevalence of retinopathy in caucasian type II diabetic patients from the south of Brazil and relationship with clinical and metabolic factors. Braz J Med Biol Res 38:221–225
Stitt AW, Curtis TM (2005) Advanced glycation and retinal pathology during diabetes. Pharmacol Rep 57:156–168
Takahashi M, Ikeda U, Masuyama J, Funayama H, Kano S, Shimada K (1996) Nitric oxide attenuates adhesion molecule expression in human endothelial cells. Cytokine 8:817–821
Tapp RJ, Shaw JE, Harper CA, De Courten MP, Blakau B, MacCarty DJ, Taylor HR, Welborn TA, Zimmet PZ (2003) The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 26:1731–1737
Varin R, Mulder P, Tamion F, Richard V, Henry JP, Lallemand F, Lerebours G, Thuillez C (2000) Improvement of endothelial function by chronic angiotensin-coverting enzyme inhibition in heart failure: role of nitric oxide, prostanoids, oxidant stress, and bradykinin. Circulation 102:351–356
Vorkauf M, Duncker G, Nolle B, Sterry W (1993) Adhesion molecules in normal human conjunctiva. An immunohistological study using monoclonal antibodies. Graefes Arch Clin Exp Ophthalmol 231:323–330
Wilkinson-Berka JL (2004) Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide. Curr Pharm Des 10:3331–3348
Yam JC, Kwok AKh (2007) Update on the treatment of diabetic retinopathy. Hong Kong Med J 13:46–60
Acknowledgements
The authors are indebted to Ms Linda Northrup for reviewing the English version of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khalfaoui, T., Lizard, G. & Ouertani-Meddeb, A. Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes. J Mol Hist 39, 243–249 (2008). https://doi.org/10.1007/s10735-007-9159-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-007-9159-5